{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T05:07:07Z","timestamp":1775279227559,"version":"3.50.1"},"reference-count":42,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,4,1]]},"DOI":"10.5551\/jat.65868","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:08:17Z","timestamp":1760220497000},"page":"428-440","source":"Crossref","is-referenced-by-count":0,"title":["<i>Chlamydia pneumoniae<\/i> Seropositivity is Associated with Cardiovascular Events in the General Population: The Nagahama Study"],"prefix":"10.5551","volume":"33","author":[{"given":"Aya","family":"Ogawa","sequence":"first","affiliation":[{"name":"Graduate School of Public Health, Shizuoka Graduate University of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Shoji-Asahina","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health, Shizuoka Graduate University of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Department of Health Informatics, Kyoto University School of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Center for Genomic Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health, Shizuoka Graduate University of Public Health"},{"name":"Center for Genomic Medicine, Kyoto University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T: Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest, 2002; 121: 1776-1781","DOI":"10.1378\/chest.121.6.1776"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Almirall J, Morat\u00f3 I, Riera F, Verdaguer A, Priu R, Coll P, Vidal J, Murgui L, Valls F, Catalan F, Balanz\u00f3 X: Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur Respir J, 1993; 6: 14-18","DOI":"10.1183\/09031936.93.06010014"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Marrie TJ, Peeling RW, Reid T, De Carolis E; Canadian Community-Acquired Pneumonia Investigators: Chlamydia species as a cause of community-acquired pneumonia in Canada. Eur Respir J, 2003; 21: 779-784","DOI":"10.1183\/09031936.03.00095403"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, Leinonen M, R\u00f6nnberg PR, Saikku P, St\u00e9n M, Tarkiainen A, Tukiainen H, Py\u00f6r\u00e4l\u00e4 K, M\u00e4kel\u00e4 PH: Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis, 2001; 32: 1141-1154","DOI":"10.1086\/319746"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Siscovick DS, Schwartz SM, Caps M, Wang SP, Grayston JT: Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology. J Infect Dis, 2000; 181: S417-420","DOI":"10.1086\/315623"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kalayoglu MV, Libby P, Byrne GI: Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA, 2002; 288: 2724-2731","DOI":"10.1001\/jama.288.21.2724"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Melnick SL, Shahar E, Folsom AR, Grayston JT, Sorlie PD, Wang SP, Szklo M: Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med, 1993; 95: 499-504","DOI":"10.1016\/0002-9343(93)90332-J"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) van der Ven AJ, Hommels MJ, Kroon AA, Kessels A, Flobbe K, van Engelshoven J, Bruggeman CA, de Leeuw PW: Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease. Arch Intern Med, 2002; 162: 786-790","DOI":"10.1001\/archinte.162.7.786"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Player MS, Mainous AG 3rd, Everett CJ, Diaz VA, Knoll ME, Wright RU: Chlamydia pneumoniae and progression of subclinical atherosclerosis. Eur J Prev Cardiol, 2014; 21: 559-565","DOI":"10.1177\/2047487312472078"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H: Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation, 1999; 100: 832-837","DOI":"10.1161\/01.CIR.100.8.832"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Agmon Y, Khandheria BK, Meissner I, Petterson TM, O\u2019Fallon WM, Christianson TJ, Wiebers DO, Smith TF, Steckelberg JM, Tajik AJ: Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study. J Am Coll Cardiol, 2003; 41: 1482-1487","DOI":"10.1016\/S0735-1097(03)00261-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Kohara K, Tabara Y, Yamamoto Y, Igase M, Miki T: Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study. Stroke, 2002; 33: 1474-1479","DOI":"10.1161\/01.STR.0000018974.05768.FB"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Wong Y, Bernardes-Silva M, Ward M: Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ, 2000; 321(7255): 208-213","DOI":"10.1136\/bmj.321.7255.208"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong YK, Zhou X, Ward M: Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J, 2002; 23: 371-375","DOI":"10.1053\/euhj.2001.2801"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ridker PM, Kundsin RB, Stampfer MJ, Poulin S, Hennekens CH: Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation, 1999; 99: 1161-1164","DOI":"10.1161\/01.CIR.99.9.1161"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE: Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol, 1999; 150: 149-156","DOI":"10.1093\/oxfordjournals.aje.a009974"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Sakurai-Komada N, Iso H, Koike KA, Ikeda A, Umesawa M, Ikehara S, Inoue M, Tsugane S: Association between Chlamydophila pneumoniae infection and risk of coronary heart disease for Japanese: the JPHC study. Atherosclerosis, 2014; 233: 338-342","DOI":"10.1016\/j.atherosclerosis.2014.01.023"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, Sweetnam PM, Elwood PC: Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ, 1999; 318: 1035-1039","DOI":"10.1136\/bmj.318.7190.1035"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O\u2019Donnell CJ, Levy D: The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J Am Coll Cardiol, 2002; 40: 1408-1413","DOI":"10.1016\/S0735-1097(02)02272-6"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Elkind MS, Lin IF, Grayston JT, Sacco RL: Chlamydia pneumoniae and the risk of first ischemic stroke: The Northern Manhattan Stroke Study. Stroke, 2000; 31: 1521-1525","DOI":"10.1161\/01.STR.31.7.1521"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Little CS, Bowe A, Lin R, Litsky J, Fogel RM, Balin BJ, Fresa-Dillon KL: Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB\/c mice. Infect Immun, 2005; 73: 1723-1734","DOI":"10.1128\/IAI.73.3.1723-1734.2005"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Reunanen A, Roivainen M, Kleemola M, Saikku P, Leinonen M, Hovi T, Knekt P, Leino A, Aromaa A: Enterovirus, mycoplasma and other infections as predictors for myocardial infarction. J Intern Med, 2002; 252: 421-429","DOI":"10.1046\/j.1365-2796.2002.01052.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Tabara Y, Matsumoto T, Murase K, Kawaguchi T, Setoh K, Wakamura T, Hirai T, Chin K, Matsuda F: Descriptive Epidemiology and Prognostic Significance of Diaphragm Thickness in the General Population: The Nagahama Study. J Cachexia Sarcopenia Muscle, 2025; 16: e13690","DOI":"10.1002\/jcsm.13690"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Takeshita M, Tabara Y, Setoh K, Nagao K, Imaizumi A, Kageyama Y, Matsuda F; Nagahama study group: Development of a plasma-free amino acid-based risk score for the incidence of cardiovascular diseases in a general population: The Nagahama study. Clin Nutr, 2023; 42: 2512-2519","DOI":"10.1016\/j.clnu.2023.10.024"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y: Predicting coronary heart disease using risk factor categories for a Japanese urban population, and comparison with the framingham risk score: the suita study. J Atheroscler Thromb, 2014; 21: 784-798","DOI":"10.5551\/jat.19356"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ridker PM, Buring JE, Rifai N, Cook NR: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA, 2007; 297: 611-619","DOI":"10.1001\/jama.297.6.611"},{"key":"27","unstructured":"27) WHO MONICA Project. MONICA Manual. (1998\u20131999). http:\/\/www.ktl.fi\/publications\/monica\/manual\/index.htm, URN:NBN:fi-fe19981146"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Barker CE, Sillis M, Wreghitt TG: Evaluation of Serodia Myco II particle agglutination test for detecting Mycoplasma pneumoniae antibody: comparison with mu-capture ELISA and indirect immunofluorescence. J Clin Pathol, 1990; 43: 163-165","DOI":"10.1136\/jcp.43.2.163"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Shankar EM, Kumarasamy N, Balakrishnan P, Vengatesan A, Kownhar H, Solomon S, Rao UA: Seroprevalence of Mycoplasma pneumoniae in HIV-infected patients using a microparticle agglutination test. J Med Microbiol, 2006; 55: 759-763","DOI":"10.1099\/jmm.0.46402-0"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kung CM, Wang HL: Seroprevalence of Mycobacterium pneumoniae in healthy adolescents in Taiwan. Jpn J Infect Dis, 2007; 60: 352-354","DOI":"10.7883\/yoken.JJID.2007.352"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y, Hori S, Yamamoto Y: Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res, 2002; 25: 359-364","DOI":"10.1291\/hypres.25.359"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Tanaka H, Munakata M, Kawano Y, Ohishi M, Shoji T, Sugawara J, Tomiyama H, Yamashina A, Yasuda H, Sawayama T, Ozawa T: Comparison between carotid-femoral and brachial-ankle pulse wave velocity as measures of arterial stiffness. J Hypertens, 2009; 27: 2022-2027","DOI":"10.1097\/HJH.0b013e32832e94e7"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sugawara J, Hayashi K, Yokoi T, Cortez-Cooper MY, DeVan AE, Anton MA, Tanaka H: Brachial-ankle pulse wave velocity: an index of central arterial stiffness? J Hum Hypertens, 2005; 19: 401-406","DOI":"10.1038\/sj.jhh.1001838"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Wu Z, Lan Y, Wu D, Chen S, Jiao R, Wu S: Arterial stiffness mediates insulin resistance-related risk of atherosclerotic cardiovascular disease: a real-life, prospective cohort study. Eur J Prev Cardiol, 2025: zwaf030","DOI":"10.1093\/eurjpc\/zwaf030"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Joshi R, Khandelwal B, Joshi D, Gupta OP: Chlamydophila pneumoniae infection and cardiovascular disease. N Am J Med Sci, 2013; 5: 169-181","DOI":"10.4103\/1947-2714.109178"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Segers P, Rietzschel ER, Chirinos JA: How to measure arterial stiffness in humans. Arterioscler Thromb Vasc Biol, 2020; 40: 1034-1043","DOI":"10.1161\/ATVBAHA.119.313132"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Taniwaki H, Kawagishi T, Emoto M, Shoji T, Kanda H, Maekawa K, Nishizawa Y, Morii H: Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care, 1999; 22: 1851-1857","DOI":"10.2337\/diacare.22.11.1851"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kobayashi K, Akishita M, Yu W, Hashimoto M, Ohni M, Toba K: Interrelationship between non-invasive measurements of atherosclerosis: flow-mediated dilation of brachial artery, carotid intima-media thickness and pulse wave velocity. Atherosclerosis, 2004; 173: 13-18","DOI":"10.1016\/j.atherosclerosis.2003.10.013"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR; C. pneumoniae Workshop Participants: Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis, 2001; 33: 492-503","DOI":"10.1086\/322632"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Persson K, Boman J: Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae. Clin Diagn Lab Immunol, 2000; 7: 739-744","DOI":"10.1128\/CDLI.7.5.739-744.2000"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Numazaki K, Ikebe T, Chiba S: Detection of serum antibodies against Chlamydia pneumoniae by ELISA. FEMS Immunol Med Microbiol, 1996; 14: 179-183","DOI":"10.1111\/j.1574-695X.1996.tb00285.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Gramegna A, Sotgiu G, Di Pasquale M, Radovanovic D, Terraneo S, Reyes LF, Vendrell E, Neves J, Menzella F, Blasi F, Aliberti S, Restrepo MI; GLIMP Study Group: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective. BMC Infect Dis, 2018; 18: 677","DOI":"10.1186\/s12879-018-3565-z"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65868\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:25:16Z","timestamp":1775276716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/4\/33_65868\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.65868","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"article-number":"65868"}}